Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation.
about
MUC1-C Oncoprotein Blocks Terminal Differentiation of Chronic Myelogenous Leukemia Cells by a ROS-Mediated MechanismTracking of Normal and Malignant Progenitor Cell Cycle Transit in a Defined Niche.NOTCH1 signaling promotes human T-cell acute lymphoblastic leukemia initiating cell regeneration in supportive nichesA novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions.NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AMLClonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia.microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia.Chronic myeloid leukemia: mechanisms of blastic transformationThe intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia.The elusive chronic myeloid leukemia stem cell: does it matter and how do we eliminate it?Breast cancer stem cells: Multiple capacities in tumor metastasis.Wnt signaling in cancerMultiple alternative splicing and differential expression pattern of the glycogen synthase kinase-3β (GSK3β) gene in goat (Capra hircus)Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remissionA novel Bcr-Abl-mTOR-eIF4A axis regulates IRES-mediated translation of LEF-1Heterogeneous sensitivity of human acute myeloid leukemia to β-catenin down-modulation.BCR-ABL1-associated reduction of beta catenin antagonist Chibby1 in chronic myeloid leukemiaAn RNA editing fingerprint of cancer stem cell reprogramming.cml biology for the clinician in 2011: six impossible things to believe before breakfast on the way to cure.Clinicopathological significance of wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.14-3-3 Binding and Sumoylation Concur to the Down-Modulation of β-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia.Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cellsA genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets.Cell-selective inhibition of NF-κB signaling improves therapeutic index in a melanoma chemotherapy model.Alternative approaches to eradicating the malignant clone in chronic myeloid leukemia: tyrosine-kinase inhibitor combinations and beyond.Setbp1 promotes the self-renewal of murine myeloid progenitors via activation of Hoxa9 and Hoxa10Wnts are dispensable for differentiation and self-renewal of adult murine hematopoietic stem cells.β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia.Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal.ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia.Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes.Fas-associated phosphatase 1 (Fap1) influences βcatenin activity in myeloid progenitor cells expressing the Bcr-abl oncogeneIL-1β-driven neutrophilia preserves antibacterial defense in the absence of the kinase IKKβTargeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell functionThe PI3K/Akt1 pathway enhances steady-state levels of FANCL.Hydrogen peroxide (H2O2) induces leukemic but not normal hematopoietic cell death in a dose-dependent manner.Myeloid Cell Origins, Differentiation, and Clinical Implications.Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention.Niche WNT5A regulates the actin cytoskeleton during regeneration of hematopoietic stem cellsChronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues.
P2860
Q24626837-A97E1E32-C4D3-454B-8C17-4D7114D49581Q27324269-832515BE-63A1-4D63-968F-E640F2AA73A1Q28727674-76B7A1FD-B80B-4B97-8A99-EBC3A17D1F30Q30504566-3E7A73AC-67B6-448D-94CC-786609036E0DQ33556923-053CC441-75D3-49A1-9810-219C92EB7CB6Q33711497-CF5909DF-18D2-4034-8C44-999927C8E342Q33730103-9EBB4716-F681-46A1-9B6B-73D24D8BF3FEQ33968037-723BA07A-7154-4AE4-ACC1-191D55ECCD32Q34156754-17AC3FC3-D011-48D7-A7C2-5DFE06795E90Q34167708-96B93889-0342-403F-B2A5-2BA991A0DC93Q34257303-0C1A1639-93FB-429C-BFB5-B1970775B476Q34262857-5F95D33A-3DC0-4AA3-AB11-635A07A5B73BQ34343577-11D988B2-04ED-41A1-9765-5F62C99574B3Q34405195-8209EB8B-C470-4528-A5B2-67CC8243F6DBQ34589167-2514C224-50F0-4BFF-889E-91B66D8F141CQ34905557-F3213CF3-C9DE-463C-B475-C6EA923CAF12Q35067505-FCBDF173-08CC-4071-95D2-25FF905AA037Q35124728-32D728B9-8E42-48FB-BDE5-646438D7F3D9Q35145688-D7C209F2-A31E-4DB9-B5B4-8BAC73F37BF5Q35632278-78E7CC29-8264-4156-B196-038F866358FBQ35683215-7D53A471-11BF-4C28-AA90-58F353765206Q35685058-F300ACB8-D83F-4DA6-9EBB-D95D3AC8AF59Q35690609-D7CA1689-605E-483C-9F2B-9CCD947CA995Q35790145-A617CF80-4221-4983-A20C-95733B40B925Q35931271-4BB89833-F83C-40CE-BFC4-2DF44F58CC14Q36057892-14BA3280-F176-4AE9-B247-BA99D5C68D70Q36137248-03B0916A-E4B9-45BF-8361-716E808F8D16Q36362945-6ED08678-4050-47BD-BE9D-8F010D80AF22Q36394240-C1339E61-997E-49B0-84B4-C2F39D784633Q36545514-F579D6B9-520D-4F1A-AF15-2BE0C40A4932Q36637556-DDF756FD-35B7-493F-81D5-E714E6D5EB1FQ36812412-CB091C54-C542-4020-B3A3-11DA12B121F0Q36914486-8AF56A84-C087-4A1A-8C74-FCFB08D26036Q36950337-543B0528-C0A6-476F-8C0E-4F2EE0557820Q37098762-82C4BABE-9EE4-48A3-9273-E7B38ED4FDA7Q37425328-B53C47A2-CB7E-476B-B72D-49892FC91196Q37429070-BF400D44-9A37-4F09-A94C-F14FD3A2FCB4Q37460101-51B24726-AEE4-499A-83A4-8F48403E6EEEQ37549702-3B1C05C3-6D6C-4E43-9C79-98F38DF1BF66Q37566249-13B2558F-8184-449D-A709-4D9B9AD86E94
P2860
Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation.
@en
Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation.
@nl
type
label
Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation.
@en
Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation.
@nl
prefLabel
Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation.
@en
Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation.
@nl
P2093
P2860
P356
P1476
Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation.
@en
P2093
Annelie E Abrahamsson
Armand Keating
Carol Jones
Catriona H M Jamieson
Charlene F Barroga
Francis J Giles
Ifat Geron
Irving L Weissman
Isabel G Newton
James L Zehnder
P2860
P304
P356
10.1073/PNAS.0900189106
P407
P577
2009-02-23T00:00:00Z